Orbuculum - Axilor Ventures :: Axilor Ventures is an Active Seed Fund

Post date August 27, 2018

Orbuculum uses AI on genome data to predict diseases such as cancer, diabetes, and other chronic diseases.

< back to BLOG HOME

Also read

High capital availability, low momentum – Paradox of DeepTech investing

4 min read

Demystifying Supply Chains – The Axilor Rundown

4 min read

Decarbonising supply chains: complex, yet the need of the hour.

5 min read

Axilor launches its second seed fund of $100m

4 min read

×